[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355300-105":59,"doc-detail-355300-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","machine-learning-driven-multi-omics-analysis-identifies-chp2-as-a-key-panoptosis-related-dual-function-biomarker-in-colorectal-cancer","Machine Learning-Driven Multi-Omics Analysis Identifies CHP2 as a Key PANoptosis-Related Dual-Function Biomarker in Colorectal Cancer","","Heterogeneous colorectal cancer (CRC) presents major therapeutic challenges. This study integrates multi-omics data with machine learning and interprets the drivers using SHAP models to nominate Calcineurin B Homologous Protein 2 (CHP2) as a central candidate, confirmed through in vitro experiments and zebrafish models. CHP2 expression is reduced in CRC, correlating with poor prognosis and an immunosuppressed “cold” tumor immune microenvironment. CHP2 overexpression suppresses growth and invasion by inducing PANoptosis, and distinct CHP2 profiles stratify high-risk patients resistant to standard chemotherapy while remaining responsive to targeted inhibitors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/machine-learning-driven-multi-omics-analysis-identifies-chp2-as-a-key-panoptosis-related-dual-function-biomarker-in-colorectal-cancer/355300/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/machine-learning-driven-multi-omics-analysis-identifies-chp2-as-a-key-panoptosis-related-dual-function-biomarker-in-colorectal-cancer/355300.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How was CHP2 identified in this study?","Question",{"text":112,"@type":113},"The study integrates multi-omics with machine learning, uses SHAP models for interpretation, and selects CHP2 as a core candidate. It then validates the findings using in vitro and zebrafish models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What clinical significance does CHP2 have in colorectal cancer?",{"text":117,"@type":113},"Low CHP2 expression characterizes a high-risk group linked to an immunosuppressive “cold” tumor microenvironment and poor prognosis. CHP2 expression profiles also discriminate patients likely resistant to standard chemotherapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What biological role does CHP2 play regarding tumor cell behavior?",{"text":121,"@type":113},"Functionally, CHP2 overexpression inhibits cell growth and invasion by inducing PANoptosis, which involves necroptosis, pyroptosis, and apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355300,1790240974,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Article  \nMachine Learning-Driven Multi-Omics Analysis Identifies CHP2 as a Key PANoptosis-Related Dual-Function Biomarker in Colorectal Cancer  \nZetian Zhang 1, Xingyu Jiang 1, Xin Zhang 1 and Fan Li 1,2,3,4,5, *  \nAcademic Editor: Steve Shnyder  \nReceived: 14 December 2025  \nRevised: 23 February 2026  \nAccepted: 26 February 2026  \nPublished: 28 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 The Key Laboratory of Zoonosis, Department of Pathogen Biology, Chinese Ministry of Education, College of Basic Medical Sciences, Jilin University, Changchun 130000, China  \n2 The Key Laboratory for Bionics Engineering, Ministry of Education, Jilin University, Changchun 130000, China  \n3 Engineering Research Center for Medical Biomaterials of Jilin Province, Jilin University, Changchun 130000, China  \n4 Key Laboratory for Health Biomedical Materials of Jilin Province, Jilin University, Changchun 130000, China  \n5 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi 830000, China  \n* Correspondence: [lifan1956@163.com](lifan1956@163.com)  \nHighlights  \nWhat are the main findings?  \n• CHP2 was identified as a key tumor suppressor in colorectal cancer that inhibits cell proliferation and invasion by triggering PANoptosis (necroptosis, pyroptosis, and apoptosis).  \n• Low CHP2 expression characterizes a high-risk patient group associated with an immunosuppressive “cold” tumor microenvironment and poor clinical prognosis.  \nWhat are the implications of the main findings?  \n• CHP2 serves as a dual-function biomarker, providing a molecular basis for both prognostic risk stratification and the prediction of therapeutic response.  \n• CHP2 deficiency identifies patients resistant to standard chemotherapy who may selectively benefit from targeted inhibitors such as Ribociclib or Lapatinib.  \nAbstract  \nThe heterogeneity of colorectal cancer (CRC) represents a great challenge in therapy. We integrated multiomics and machine learning, interpreted by SHAP models to provide a clinical rationale, to identify Calcineurin B Homologous Protein 2 (CHP2) as a core candidate, which was further validated via in vitro and zebrafish models. The expression of CHP2 are decreased in CRC, which is associated with a poor prognosis and an immune suppressed “cold” TIME. Functionally, CHP2 overexpression inhibits cell growth and invasion by inducing PANoptosis. Clinically, specific CHP2 expression profiles discriminate patients at high risk that are resistant to standard chemotherapy (e.g., 5-FU) but sensitive to targeted inhibitors. CHP2 is a powerful dual-function biomarker—prognostic for survival and predictive for the response to therapy—that could lead to a personalized approach in treating drug-resistant CRC.  \nKeywords: calcineurin B homologous protein 2; PANoptosis; colorectal cancer; tumor immune microenvironment; machine learning-driven multiomics analysis; dualfunction biomarker  \n1. Introduction  \nColorectal cancer (CRC) is a severe hazard to public health. It is the third most common type of cancer and the second most common cause of cancer-related death worldwide. There has been a significant increase in the number of cases in recent decades [1] . It causes approximately 10% of all malignancies and cancer-related deaths that are diagnosed each year worldwide. Despite the fact that CRC is the third most prevalent cancer in males and ranks second most frequently in females, women have a 25% lower incidence and fatality rate than men do [2] . These rates also exhibit geographical variations, with the highest figures reported in more developed nations [3] . Although early screening has decreased the incidence and mortality of CRC, 25–50% of individuals who receive an early diagnosis will later develop metastases, and 25% of pati","cbCaictnebjk3GQX","https://ap.wps.com/l/cbCaictnebjk3GQX","pdf",10795757,28,"English","# Highlights\n## Main findings\n## Implications of the main findings\n# Abstract\n# Keywords\n# Introduction","[{\"question\":\"How was CHP2 identified in this study?\",\"answer\":\"The study integrates multi-omics with machine learning, uses SHAP models for interpretation, and selects CHP2 as a core candidate. It then validates the findings using in vitro and zebrafish models.\"},{\"question\":\"What clinical significance does CHP2 have in colorectal cancer?\",\"answer\":\"Low CHP2 expression characterizes a high-risk group linked to an immunosuppressive “cold” tumor microenvironment and poor prognosis. CHP2 expression profiles also discriminate patients likely resistant to standard chemotherapy.\"},{\"question\":\"What biological role does CHP2 play regarding tumor cell behavior?\",\"answer\":\"Functionally, CHP2 overexpression inhibits cell growth and invasion by inducing PANoptosis, which involves necroptosis, pyroptosis, and apoptosis.\"}]","Machine Learning-Driven Multi-Omics Analysis Identifies CHP2 as a Key PANoptosis-Related Dual-Function Biomarker in Colorectal Cancer | PDF",1790117531,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/234842bec869ea2a73d1ef9030a040ad.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/83e2432aeddc8af723dfafd1e057d9e2.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec0db327e0ddd542ac0073d208f31593.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3cadd173e2b39c51acb67f3226265797.webp",980,1385]